Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo Boccuzzi

Showing results (31-40 of 95) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 21, 2009
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationaleFlavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, et al.
The American Journal of Medicine|May 3, 2011
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trialFlavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
International Journal of Cardiology|November 27, 2020
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter studyGavino Casu, Giuseppe D'Angelo, Fabrizio Ugo, et al.
Cardiac Failure Review|May 11, 2022
Pulmonary Artery Catheter Monitoring in Patients with Cardiogenic Shock: Time for a Reappraisal?Maurizio Bertaina, Alessandro Galluzzo, Nuccia Morici, et al.
European Heart Journal|May 23, 2018
Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stentsGiulio Guagliumi, Kunihiro Shimamura, Vasile Sirbu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 16, 2021
Comparison of ECMO vs ECpella in Patients With Non-Post-Pericardiotomy Cardiogenic Shock: An Updated Meta-AnalysisMario Iannaccone, Giuseppe Venuti, Emanuela di Simone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)Luca Testa, Marco De Carlo, Alessandro Petrolini, et al.
International Journal of Cardiology|April 25, 2018
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]Hiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
The American Journal of Cardiology|January 30, 2017
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)Fabrizio D'Ascenzo, Alaide Chieffo, Enrico Cerrato, et al.
Pageof 10

Showing results (31-40 of 95) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 21, 2009
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationaleFlavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, et al.
The American Journal of Medicine|May 3, 2011
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trialFlavio Ribichini, Fabrizio Tomai, Giuseppe De Luca, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
International Journal of Cardiology|November 27, 2020
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter studyGavino Casu, Giuseppe D'Angelo, Fabrizio Ugo, et al.
Cardiac Failure Review|May 11, 2022
Pulmonary Artery Catheter Monitoring in Patients with Cardiogenic Shock: Time for a Reappraisal?Maurizio Bertaina, Alessandro Galluzzo, Nuccia Morici, et al.
European Heart Journal|May 23, 2018
Temporal course of vascular healing and neoatherosclerosis after implantation of durable- or biodegradable-polymer drug-eluting stentsGiulio Guagliumi, Kunihiro Shimamura, Vasile Sirbu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 16, 2021
Comparison of ECMO vs ECpella in Patients With Non-Post-Pericardiotomy Cardiogenic Shock: An Updated Meta-AnalysisMario Iannaccone, Giuseppe Venuti, Emanuela di Simone, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)Luca Testa, Marco De Carlo, Alessandro Petrolini, et al.
International Journal of Cardiology|April 25, 2018
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]Hiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
The American Journal of Cardiology|January 30, 2017
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)Fabrizio D'Ascenzo, Alaide Chieffo, Enrico Cerrato, et al.
Pageof 10